APVO - Why Aptevo Therapeutics Stock Is Cratering | Benzinga
Aptevo Therapeutics Inc. (NASDAQ:APVO) shares are trading lower Thursday after the company priced its $4.6 million public offering.
The Details:
Aptevo announced the pricing of a public offering of 3,400,000 shares of its common stock or pre-funded warrants in lieu thereof and warrants to purchase up to an aggregate of 6,800,000 shares of its common stock at a purchase price of $1.35 per share.
Aptevo shares are dropping on heavy trading volume. According to data from Benzinga Pro, more than 3.8 million shares have been traded in the session, compared to the stock’s 100-day average of slightly more than 138,000 shares.
Related News: What’s Going ...